# Biodexa Pharmaceuticals Plc: Form 6-K, filed Oct 8, 2026

- Company: [Biodexa Pharmaceuticals Plc](/companies/bdrx.md) (CIK 1643918)
- Form: 6-K
- Filed: 2026-10-08
- Accepted by EDGAR: Oct 8, 2026, 16:03 ET
- Period: 2026-10-08
- Accession: 0001214659-26-012706
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1643918/000121465926012706/g1082626k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1643918/000121465926012706/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1643918/000121465926012706/g1082626k.htm

Filed Oct 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001214659-26-012706. Last ingested by Listed: Nov 9, 2026, 17:57 ET. No prices; not investment advice.
